Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease
Authors not listed
Molecular NeuroImaging · 2015
Abstract
The primary objective of this exploratory imaging study is to further characterize \[18F\]T807, an investigational PET radioligand for imaging Tau (thought to be a downstream biomarker indicative of neurodegeneration in conditions such as AD).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2015). Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease. <em>Molecular NeuroImaging</em>. https://clinicaltrials.gov/study/NCT02370524
Vancouver
Anonymous. Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease. Molecular NeuroImaging. 2015.
BibTeX
@misc{anon2015Quanti,
title = {Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease},
author = {Anonymous},
journal = {Molecular NeuroImaging},
year = {2015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Pennsylvania 2022
Open access · US-GOV
Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Disease Using the PET Ligand [18F]-PI-2620
University of Pennsylvania 2014
Open access · US-GOV
[18F]-T807 PET/CT Imaging of Tau Pathology in Young Onset Focal Dementia
Tammie L. S. Benzinger, MD, PhD 2014
Open access · US-GOV
F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A
Johns Hopkins University 2020
Open access · US-GOV
Comparison of [18F]RO-948, [18F]MK-6240, and [18F]AV-1451 TAU Radiopharmaceuticals in Patients With Alzheimer's Disease and Older Controls
University of Wisconsin, Madison 2019
Open access · US-GOV
Longitudinal Evaluation of [18-F]MK-6240 as a Novel Tau PET Radiotracer in Patients With Alzheimer's Disease Dementia or Mild Cognitive Impairment Compared to Healthy Volunteers
Avid Radiopharmaceuticals 2009
Open access · US-GOV